Melinta Therapeutics Inc. buy Mori8
Start price
29.10.18
/
50%
€10.64
Target price
30.05.19
€22.55
Performance (%)
-80.76%
End price
30.05.19
€2.05
Summary
This prediction ended on 30.05.19 with a price of €2.05. Massive losses of -80.76% were the result for the BUY prediction by Mori8. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% | 17.330% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% | 50.534% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% | 43.432% |
Comments by Mori8 for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
Mori8 stimmt der Buy-Einschätzung von Quitte zu
Mori8 stimmt am 29.10.2018 der Buy-Einschätzung von Quitte mit dem Kursziel 5$ zu.
Überschrift: Quitte stimmt der Buy-Einschätzung von stratec zu
(Vom Mitglied beendet)
Stopped prediction by Mori8 for Melinta Therapeutics Inc.
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.25
11.02.20
11.02.20
€2.00
09.03.20
09.03.20
-32.40%
09.03.20
09.03.20
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.06
05.09.19
05.09.19
€2.00
11.02.20
11.02.20
-87.57%
11.02.20
11.02.20